article Open Access
Study of neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio in patients diagnosed with gastric carcinoma
International Journal of Surgery Science · 2019 · Vol. 3(4) · pp. 292–295
Abstract
Background: Carcinoma of the stomach stands as the fourth most common type of cancer worldwide but there have been no specific biomarkers has been identified for GC. Present studywas aimed to evaluate Neutrophil to Lymphocyte ratio and Lymphocyte to Monocyte Ratio in patients diagnosed with Gastric Carcinoma. Present study was aimed to evaluate Neutrophil to Lymphocyte ratio and Lymphocyte to Monocyte Ratio in patients diagnosed with Gastric Carcinoma.
Inflammatory Biomarkers in Disease PrognosisMetastasis and carcinoma case studiesGastric Cancer Management and OutcomesMonocyteLymphocyteMedicineGastric carcinomaCancerNeutrophil to lymphocyte ratioCarcinomaInternal medicineStomachImmunology
Citations
0
FWCI
0.00
field-weighted impact
References
18
Percentile
38%
vs. same field & year
References
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
The Lancet · 2010 · 7,196 citations
Cancer statistics, 2020
CA A Cancer Journal for Clinicians · 2020 · 21,282 citations
Related articles
Study of neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio in patients diagnosed with gastric carcinoma
International Journal of Surgery Science · 2019 · 0 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.